<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the effect of a first-degree family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> on the intima-media thickness of the common carotid artery (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>-CCA), a surrogate marker of <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo>, in <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant young adults </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>-CCA was measured by high-resolution B-mode ultrasound imaging in 401 individuals aged 18-45 years with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 213 subjects had no family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> until the third generation (FH(-)), and 188 subjects had a family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (FH(+)), defined as having one or both parents with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Other measurements included: central fat accumulation, evaluated by waist circumference; <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, estimated by homeostasis model assessment for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (HOMA(IR)); systolic and diastolic blood pressure; fasting and postload concentrations of <z:chebi fb="105" ids="17234">glucose</z:chebi>; fasting insulin levels; and <z:chebi fb="23" ids="18059">lipid</z:chebi> profile </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>-CCA and both 1- and 2-h postchallenge <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations were significantly higher in FH(+) than in FH(-) subjects </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>-CCA was positively correlated with age, BMI, waist circumference, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, systolic and diastolic blood pressure levels, basal <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations, 1- and 2-h postchallenge <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations, and HOMA(IR) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>-CCA was inversely associated with <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>After multivariate analysis, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>-CCA maintained a significant association with family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, BMI, waist circumference, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, diastolic blood pressure, and fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: This study indicates that a genetic predisposition to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, probably in association with slightly elevated <z:chebi fb="105" ids="17234">glucose</z:chebi> levels, may accelerate the development of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and increase the risk for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> in <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant individuals </plain></SENT>
</text></document>